James W. Jr. Newman Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for James W. Jr. Newman.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of James W. Jr. Newman. James W. Jr. Newman is Director in ADIAL PHARMACEUTICALS, INC. ($ADIL).
Latest Insider Trading Transactions of James W. Jr. Newman
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 10 2021 | ADIL | ADIAL PHARMACEUTIC ... | Newman James W. Jr. | Director | Option Exercise | A | 3.11 | 40,000 | 124,400 | 40,000 | |
| Jan 28 2021 | ADIL | ADIAL PHARMACEUTIC ... | Newman James W. Jr. | Director | Grant | A | 0.00 | 2,544 | 0 | 152,963 | 150.4 K to 153 K (+1.69 %) |
| Jan 28 2021 | ADIL | ADIAL PHARMACEUTIC ... | Newman James W. Jr. | Director | Grant | A | 0.00 | 1,187 | 0 | 14,475 | 13.3 K to 14.5 K (+8.93 %) |
| Mar 30 2020 | ADIL | ADIAL PHARMACEUTIC ... | Newman James W. Jr. | Director | Buy | P | 1.35 | 4,644 | 6,269 | 14,644 | 10 K to 14.6 K (+46.44 %) |
| Mar 30 2020 | ADIL | ADIAL PHARMACEUTIC ... | Newman James W. Jr. | Director | Buy | P | 1.34 | 10,000 | 13,400 | 13,288 | 3.3 K to 13.3 K (+304.14 %) |
| Mar 30 2020 | ADIL | ADIAL PHARMACEUTIC ... | Newman James W. Jr. | Director | Buy | P | 1.42 | 5,000 | 7,100 | 15,000 | 10 K to 15 K (+50.00 %) |
| Mar 05 2020 | ADIL | ADIAL PHARMACEUTIC ... | Newman James W. Jr. | Director | Option Exercise | A | 1.44 | 60,000 | 86,400 | 60,000 | |
| Nov 13 2018 | ADIL | ADIAL PHARMACEUTIC ... | Newman James W. Jr. | Director | Option Exercise | J | 6.25 | 92,000 | 575,000 | 92,000 | |
| Nov 13 2018 | ADIL | ADIAL PHARMACEUTIC ... | Newman James W. Jr. | Director | Option Exercise | J | 5.00 | 92,000 | 460,000 | 92,000 | |
| Nov 13 2018 | ADIL | ADIAL PHARMACEUTIC ... | Newman James W. Jr. | Director | Option Exercise | J | 5.00 | 92,000 | 460,000 | 0 | |
| Nov 13 2018 | ADIL | ADIAL PHARMACEUTIC ... | Newman James W. Jr. | Director | Option Exercise | J | 6.25 | 20,000 | 125,000 | 20,000 | |
| Nov 13 2018 | ADIL | ADIAL PHARMACEUTIC ... | Newman James W. Jr. | Director | Option Exercise | J | 5.00 | 20,000 | 100,000 | 20,000 | |
| Nov 13 2018 | ADIL | ADIAL PHARMACEUTIC ... | Newman James W. Jr. | Director | Option Exercise | J | 5.00 | 20,000 | 100,000 | 0 | |
| Aug 02 2018 | ADIL | ADIAL PHARMACEUTIC ... | Newman James W. Jr. | Director | Option Exercise | P | 6.25 | 10,000 | 62,500 | 10,000 | |
| Aug 02 2018 | ADIL | ADIAL PHARMACEUTIC ... | Newman James W. Jr. | Director | Option Exercise | P | 6.25 | 10,000 | 62,500 | 102,000 | |
| Aug 02 2018 | ADIL | ADIAL PHARMACEUTIC ... | Newman James W. Jr. | Director | Option Exercise | J | 5.00 | 92,000 | 460,000 | 92,000 | |
| Aug 02 2018 | ADIL | ADIAL PHARMACEUTIC ... | Newman James W. Jr. | Director | Option Exercise | J | 5.00 | 20,000 | 100,000 | 20,000 | |
| Aug 02 2018 | ADIL | ADIAL PHARMACEUTIC ... | Newman James W. Jr. | Director | Option Exercise | J | 6.25 | 92,000 | 575,000 | 92,000 | |
| Aug 02 2018 | ADIL | ADIAL PHARMACEUTIC ... | Newman James W. Jr. | Director | Option Exercise | J | 6.25 | 20,000 | 125,000 | 25,178 | |
| Aug 02 2018 | ADIL | ADIAL PHARMACEUTIC ... | Newman James W. Jr. | Director | Option Exercise | J | 6.25 | 5,178 | 32,363 | 5,178 | |
| Aug 02 2018 | ADIL | ADIAL PHARMACEUTIC ... | Newman James W. Jr. | Director | Option Exercise | J | 6.25 | 21,715 | 135,719 | 21,715 | |
| Aug 02 2018 | ADIL | ADIAL PHARMACEUTIC ... | Newman James W. Jr. | Director | Option Exercise | J | 6.25 | 29,931 | 187,069 | 29,931 | |
| Aug 02 2018 | ADIL | ADIAL PHARMACEUTIC ... | Newman James W. Jr. | Director | Option Exercise | C | 0.44 | 5,178 | 2,278 | 0 | |
| Aug 02 2018 | ADIL | ADIAL PHARMACEUTIC ... | Newman James W. Jr. | Director | Option Exercise | C | 0.44 | 21,715 | 9,555 | 0 | |
| Aug 02 2018 | ADIL | ADIAL PHARMACEUTIC ... | Newman James W. Jr. | Director | Option Exercise | C | 0.44 | 29,931 | 13,170 | 0 | |
| Aug 02 2018 | ADIL | ADIAL PHARMACEUTIC ... | Newman James W. Jr. | Director | Buy | P | 0.00 | 10,000 | 0 | 10,000 | 0 to 10 K |
| Aug 02 2018 | ADIL | ADIAL PHARMACEUTIC ... | Newman James W. Jr. | Director | Buy | P | 0.00 | 10,000 | 0 | 150,419 | 140.4 K to 150.4 K (+7.12 %) |
| Aug 02 2018 | ADIL | ADIAL PHARMACEUTIC ... | Newman James W. Jr. | Director | Buy | J | 0.00 | 92,000 | 0 | 140,419 | 48.4 K to 140.4 K (+190.01 %) |
| Aug 02 2018 | ADIL | ADIAL PHARMACEUTIC ... | Newman James W. Jr. | Director | Buy | J | 0.00 | 20,000 | 0 | 35,094 | 15.1 K to 35.1 K (+132.50 %) |
| Aug 02 2018 | ADIL | ADIAL PHARMACEUTIC ... | Newman James W. Jr. | Director | Buy | C | 0.00 | 5,178 | 0 | 15,221 | 10 K to 15.2 K (+51.56 %) |
| Aug 02 2018 | ADIL | ADIAL PHARMACEUTIC ... | Newman James W. Jr. | Director | Buy | C | 0.00 | 21,715 | 0 | 58,419 | 36.7 K to 58.4 K (+59.16 %) |
| Aug 02 2018 | ADIL | ADIAL PHARMACEUTIC ... | Newman James W. Jr. | Director | Buy | C | 0.00 | 29,931 | 0 | 41,160 | 11.2 K to 41.2 K (+266.55 %) |
Page: 1